DE3881953D1 - Expression von fremden genen in drosophila-zellen. - Google Patents

Expression von fremden genen in drosophila-zellen.

Info

Publication number
DE3881953D1
DE3881953D1 DE8888304093T DE3881953T DE3881953D1 DE 3881953 D1 DE3881953 D1 DE 3881953D1 DE 8888304093 T DE8888304093 T DE 8888304093T DE 3881953 T DE3881953 T DE 3881953T DE 3881953 D1 DE3881953 D1 DE 3881953D1
Authority
DE
Germany
Prior art keywords
foreign genes
expression
drosophila cells
drosophila
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888304093T
Other languages
English (en)
Other versions
DE3881953T2 (de
Inventor
Hanne Ranch Johansen
Der Straten-Ponthoz Ariane A Van
Martin Rosenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Application granted granted Critical
Publication of DE3881953D1 publication Critical patent/DE3881953D1/de
Publication of DE3881953T2 publication Critical patent/DE3881953T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/90—Vectors containing a transposable element
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/75—Vector systems having a special element relevant for transcription from invertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE88304093T 1987-05-08 1988-05-06 Expression von fremden Genen in Drosophila-Zellen. Expired - Lifetime DE3881953T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4773687A 1987-05-08 1987-05-08

Publications (2)

Publication Number Publication Date
DE3881953D1 true DE3881953D1 (de) 1993-07-29
DE3881953T2 DE3881953T2 (de) 1993-09-30

Family

ID=21950656

Family Applications (1)

Application Number Title Priority Date Filing Date
DE88304093T Expired - Lifetime DE3881953T2 (de) 1987-05-08 1988-05-06 Expression von fremden Genen in Drosophila-Zellen.

Country Status (13)

Country Link
EP (1) EP0290261B1 (de)
JP (1) JP2706260B2 (de)
AT (1) ATE90969T1 (de)
AU (1) AU618952B2 (de)
CA (1) CA1341345C (de)
CY (1) CY1929A (de)
DE (1) DE3881953T2 (de)
DK (1) DK175595B1 (de)
ES (1) ES2058274T3 (de)
HK (1) HK1006852A1 (de)
IE (1) IE63005B1 (de)
PT (1) PT87424B (de)
ZA (1) ZA883213B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01108995A (ja) * 1987-10-23 1989-04-26 Hoechst Japan Kk 培養動物細胞による蛋白質の産生を向上させるための遺伝子増幅方法
CA2003794C (en) * 1988-12-01 2000-02-08 Hanne R. Johansen Expression of hiv proteins in drosophila cells
JPH03504082A (ja) * 1988-12-21 1991-09-12 スミスクライン・バイオロジカルズ 昆虫細胞によるプラスモディウム属サーカムスポロゾイト蛋白の発現

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR241654A1 (es) * 1982-05-05 1992-10-30 Genentech Inc Procedimiento para producir activador de plasminogeno de tejido humano.
AU572108B2 (en) * 1983-01-19 1988-05-05 Genentech Inc. Human tpa production using vectors coding for dhfr protein
AU593264B2 (en) * 1985-07-10 1990-02-08 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Chromosomal DNA sequence, expression vector for human tissue plasminogen activating factor, cultured cells transfected with same and method of producing said activating factor
JP2515299B2 (ja) * 1986-06-03 1996-07-10 三井東圧化学株式会社 ヒ−トシヨツクたんぱく質遺伝子ｈｓｐ８３を含む発現ベクタ−及びこれを用いる誘導的発現

Also Published As

Publication number Publication date
ES2058274T3 (es) 1994-11-01
EP0290261B1 (de) 1993-06-23
IE881373L (en) 1988-11-08
JP2706260B2 (ja) 1998-01-28
ATE90969T1 (de) 1993-07-15
AU618952B2 (en) 1992-01-16
DK243388A (da) 1988-11-09
AU1551088A (en) 1988-11-10
PT87424A (pt) 1989-05-31
CA1341345C (en) 2002-03-05
EP0290261A1 (de) 1988-11-09
DK175595B1 (da) 2004-12-13
DK243388D0 (da) 1988-05-04
ZA883213B (en) 1989-03-29
DE3881953T2 (de) 1993-09-30
IE63005B1 (en) 1995-03-22
PT87424B (pt) 1992-09-30
CY1929A (en) 1997-05-16
JPS63304982A (ja) 1988-12-13
HK1006852A1 (en) 1999-03-19

Similar Documents

Publication Publication Date Title
FI862756A (fi) Fibroektiner.
DE3787356D1 (de) Expression von höheren eukaryotischen genen in aspergillus.
ES2061512T3 (es) Polipeptidos de nor-estatina y nor-cicloestatina.
ATE123787T1 (de) Herstellung von peroxid enthaltenden perfluorpolyäthern.
DE3854223T2 (de) Erzeugung und Anzeige von Rechnergraphiken.
DK155318C (da) Indoxyl- og thioindoxyl-aminosyreestere og -peptidestere, diagnostisk middel indeholdende dem, og deres anvendelse i diagnostiske midler
FI943122A0 (fi) Menetelmiä trombiinin tuottamiseksi
DK0506791T3 (da) Enzymholdigt præparat og detergent indeholdende et sådant præparat
DE69334211D1 (de) Multidrug resistenz gen
NZ219398A (en) Tissue plasminogen activator obtained from tissue culture of colon cells and its associated oligosaccharides
DE68912685D1 (de) Reinigung von Glucosaminoglucan abbauenden Enzymen.
DD130489A5 (de) Bruehe zur anzeige des vorliegens von candida-hefe und anderen pilzen
ATE90969T1 (de) Expression von fremden genen in drosophilazellen.
DE3876221D1 (de) Absorption von schwefelwasserstoff.
DE3781667T2 (de) Verwendung von 24,25-dihydroxycholecalciferol zur verhuetung des knochenalterns.
DK112290D0 (da) Vaevsplasminogenaktivator-variant
DE59309254D1 (de) Verwendung von Prothrombinfragmenten
KR890701732A (ko) 개량형 조직 플라스미노겐 활성화 인자
DE3888505T2 (de) Herstellung von Zimtsäureestern.
DE295827T1 (de) Verwendung von 24,25-dihydroxycholecalciferol bei der heilung von knochenbruechen.
ATE84315T1 (de) Rekombinante dna zur reprimierbaren und induzierbaren expression von fremdgenen.
DE69020783T2 (de) Stabilisierung von Wasserstoffsuperoxyd in Tests.
ATE48640T1 (de) Expression von pflanzlichen strukturellen genen.
ATE86292T1 (de) Verwendung von monocarbonsaeurepolyoxyalkylester - sulfonaten als schaumarme textilbehandlungsmittel.
ATE46921T1 (de) Verbesserungen in der expression von neu eingefuehrten genen in hefezellen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition